John Moore Vierling, MD, FACP, FAASLD, AGAF

Professor of Medicine
Baylor College of Medicine

John Moore Vierling, MD, FACP, FAASLD, AGAF Photo

Positions

Professor of Medicine
Medicine
Section of Gastroenterology and Hepatology
Baylor College of Medicine
Houston, Texas United States

Chief of Hepatology
Medicine
Section of Gastroenterology and Hepatology
Baylor College of Medicine
Houston, Texas United States

Director, Baylor Liver Health
Medicine
Section of Gastroenterology and Hepatology
Baylor College of Medicine
Houston, Texas United States

Professor of Surgery
Surgey
Division of Abdominal Transplantation
Baylor College of Medicine
Houston, Texas United States

Director, Advanced Liver Therapies at St. Luke's Medical Center
Medicine
Section of Gastroenterology and Hepatology
Baylor College of Medicine
Houston, Texas United States

Addresses

Abdominal Transplant & Liver Disease (Clinic)
Baylor Clinic
Suite 1450
6620 Main St.
Houston, Texas 77030
United States
Google Maps
Department of Surgery (Office)
Baylor College of Medicine
One Baylor Plaza
Mail Stop: BCM390
Houston, Texas 77030
United States
Google Maps
Advanced Liver Therapies (Lab)
Baylor Clinic
6620 Main Street
Suite 1505
Houston, Texas 77030
United States
(713) 798-1966
Google Maps

Certifications

  • Diplomate - Transplant Hepatology American Board of Internal Medicine

  • Diplomate - Gastroenterology American Board of Internal Medicine

  • Diplomate - Internal Medicine American Board of Internal Medicine

  • Diplomate National Board of Medical Examiners

Education

  • Residency at University of Rochester Strong Memorial Hospital
    06/1974 - Rochester, New York United States
  • MD from Stanford University School of Medicine
    06/1972 - Stanford, California United States

    Medicine

  • Fellowship at University of California, San Francisco School Of Medicine
    06/1978 - San Francisco, California United States
  • Research Fellowship at National Institutes of Health
    06/1977 - Bethesda, Maryland United States

Language

  • English

Gender

  • Male

Professional Statement

Dr. Vierling is board certified in internal medicine and gastroenterology and was previously certified in Transplant Hepatology from 2006-2016. He is a Fellow of the American College of Physicians, Fellow of the American Association for the Study of Liver Diseases and an American Gastroenterology Association Fellow. He was the founding Medical Director of Liver Transplantation and Director of Hepatology and instrumental in the founding of the current liver transplant program at the University of Colorado Health Sciences Center. He was subsequently the founding Medical Director of Liver Transplantation and Director of Hepatology at Cedars-Sinai Medical Center/UCLA. After 10 years as Medical Director of Liver Transplantation, he became the Medical Director of Multi-Organ Transplantation at Cedars-Sinai/UCLA. Dr. John M. Vierling directs Advanced Liver Therapies, a clinical research unit devoted to hepatobiliary diseases. He and his research staff are conducting phase 1-3 studies of diagnostics and therapies in chronic hepatitis B, chronic hepatitis C, primary biliary cirrhosis, non-alcoholic fatty liver disease, anti-fibrotic therapy to prevent cirrhosis, hepatic encephalopathy, and measurement of hepatocellular function using 13C-labeled compounds.

Professional Achievements

  • Distinguished Scientist Award
    St. Luke's Hospital

  • George Jamieson Award for Outstanding Public Service
    American Liver Foundation

  • Best Doctors in America
    01/2000 - American Health

  • America's Top Doctors
    Castle Connolly Medical Ltd.

  • Who's Who in America

  • America's Registry of Outstanding Professionals

  • Who's Who in Science and Engineering

  • Who's Who in the World
    01/2017 - Marquis Who's Who

  • Chairman, Board of Directors
    01/1999 - Arbios Systems, Inc.

  • Member, Board of Directors
    01/2019 - Athenex, Inc.

Professional Interests

  • Transplant Hepatology

  • Pre- and post-liver transplantation care

  • Liver failure

  • Hepatitis

  • Cirrhosis

  • Primary sclerosing cholangitis

  • Drug-induced liver injury

  • Wilson disease

  • Hemochromatosis

  • Alpha-1-antitrypsin deficiency

  • Hepatocellular carcinoma (HCC) and cholangocarcinoma,

  • Gastroesophageal varices

  • Hepatic encephalopathy